Fibroblast growth factor-21 (FGF-21) synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes

被引：0
|
作者：
Brenner, M. B. [1 ]
Lee, D. V. [1 ]
Bernardo, B. [1 ]
Talukdar, S. [1 ]
机构：
[1] Pfizer, CVMED, Cambridge, MA USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
541
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [21] Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity
    Tan, Bee K.
    Hallschmid, Manfred
    Adya, Raghu
    Kern, Werner
    Lehnert, Hendrik
    Randeva, Harpal S.
    DIABETES, 2011, 60 (11) : 2758 - 2762
  • [22] Characterization of Insulin Sensitivity and Resistance in Human Stem Cell-Derived Adipocytes
    Thiede, Mark A.
    Nathan, Debra F.
    Bauchmann, Mary K.
    Lee, Darwin
    Donahue, Christopher
    Man, Chiu-Fai
    Liimatta, Marya
    Kellner, Debra
    Seidl, Kelly
    Sun, Yumei L.
    Del Rosario, Amanda M.
    Owens, Bryan D.
    Boukharov, Natalia V.
    Tang, Betty
    Garofalo, Robert S.
    White, Forest M.
    DIABETES, 2009, 58 : A39 - A39
  • [23] Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action
    Krumm, C. S.
    Giesy, S. L.
    Caixeta, L. S.
    Perfield, J. W., II
    Sauerwein, H.
    Moore, B. L.
    Boisclair, Y. R.
    JOURNAL OF DAIRY SCIENCE, 2019, 102 (12) : 11586 - 11596
  • [24] Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
    Reinehr, Thomas
    Woelfle, Joachim
    Wunsch, Rainer
    Roth, Christian L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (06): : 2143 - 2150
  • [25] Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21
    Mai, Knut
    Andres, Janin
    Biedasek, Katrin
    Weicht, Jessica
    Bobbert, Thomas
    Sabath, Markus
    Meinus, Sabine
    Reinecke, Franziska
    Moehlig, Matthias
    Weickert, Martin O.
    Clemenz, Markus
    Pfeiffer, Andreas F. H.
    Kintscher, Ulrich
    Spuler, Simone
    Spranger, Joachim
    DIABETES, 2009, 58 (07) : 1532 - 1538
  • [26] Hesperidin abrogates bisphenol A endocrine disruption through binding with fibroblast growth factor 21 (FGF-21), α-amylase and α-glucosidase: an in silico molecular study
    Aja, P. M.
    Awoke, J. N.
    Agu, P. C.
    Adegboyega, A. E.
    Ezeh, E. M.
    Igwenyi, I. O.
    Orji, O. U.
    Ani, O. G.
    Ale, B. A.
    Ibiam, U. A.
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [27] Hesperidin abrogates bisphenol A endocrine disruption through binding with fibroblast growth factor 21 (FGF-21), α-amylase and α-glucosidase: an in silico molecular study
    P. M. Aja
    J. N. Awoke
    P. C. Agu
    A. E. Adegboyega
    E. M. Ezeh
    I. O. Igwenyi
    O. U. Orji
    O. G. Ani
    B. A. Ale
    U. A. Ibiam
    Journal of Genetic Engineering and Biotechnology, 20
  • [28] Fibroblast Growth Factor-21 Maintains Glucose Homeostasis through Influencing the Expansion and Function of Subcutaneous Adipose Tissue
    Li, Huating
    Qian, Lingling
    Wu, Liang
    DIABETES, 2018, 67
  • [29] Development of a physiological insulin resistance model in human stem cell-derived adipocytes
    Friesen, Max
    Khalil, Andrew S.
    Barrasa, M. Inmaculada
    Jeppesen, Jacob F.
    Mooney, David J.
    Jaenisch, Rudolf
    SCIENCE ADVANCES, 2022, 8 (24):
  • [30] Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)
    Salehi, Mohammad Hossein
    Kamalidehghan, Behnam
    Houshmand, Massoud
    Aryani, Omid
    Sadeghizadeh, Majid
    Mossalaeie, Mir Majid
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (11) : 6495 - 6499
12345